Cohen Y - Search Results

1

Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.

Cohen Y, Polliack A, Nagler A. Cohen Y, et al. Curr Pharm Des. 2003;9(3):279-88. doi: 10.2174/1381612033392134. Curr Pharm Des. 2003. PMID: 12570832 Review.

2

Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.

Cohen Y, Solal-Céligny P, Polliack A. Cohen Y, et al. Haematologica. 2003 Jul;88(7):811-23. Haematologica. 2003. PMID: 12857561 Review.

3

Treatment of refractory autoimmune diseases with ablative immunotherapy.

Cohen Y, Nagler A. Cohen Y, et al. Autoimmun Rev. 2004 Feb;3(2):21-9. doi: 10.1016/S1568-9972(03)00083-1. Autoimmun Rev. 2004. PMID: 15003184 Review.

4

Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.

Cohen Y, Nagler A. Cohen Y, et al. Isr Med Assoc J. 2002 Nov;4(11 Suppl):865-7. Isr Med Assoc J. 2002. PMID: 12455162 Review. No abstract available.

5

Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.

Cohen Y, Amir G, Rachmilewitz EA, Polliack A. Cohen Y, et al. Haematologica. 2002 Jan;87(1):ELT04. Haematologica. 2002. PMID: 11801488 No abstract available.

6

Neurotoxicity with leukoencephalopathy after a single intravenous high dose of methotrexate in a patient with lymphoma.

Cohen Y, Lossos A, Polliack A. Cohen Y, et al. Acta Haematol. 2002;107(3):185-6. doi: 10.1159/000057639. Acta Haematol. 2002. PMID: 11978942 No abstract available.

7

Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?

Cohen Y, Da'as N, Libster D, Amir G, Berrebi A, Polliack A. Cohen Y, et al. Eur J Haematol. 2002 Feb;68(2):80-3. doi: 10.1034/j.1600-0609.2002.01599.x. Eur J Haematol. 2002. PMID: 12038452

8

Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma.

Cohen Y, Amir G, Polliack A. Cohen Y, et al. Eur J Haematol. 2002 Feb;68(2):117-9. doi: 10.1034/j.1600-0609.2002.01600.x. Eur J Haematol. 2002. PMID: 12061321

9

Large B-cell lymphoma manifesting as an invasive cardiac mass: sustained local remission after combination of methotrexate and rituximab.

Cohen Y, Daas N, Libster D, Gillonb D, Polliack A. Cohen Y, et al. Leuk Lymphoma. 2002 Jul;43(7):1485-7. doi: 10.1080/1042819022386699. Leuk Lymphoma. 2002. PMID: 12389634

10

Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab.

Cohen Y, Libster D, Da'as N, Amir G, Polliack A. Cohen Y, et al. Hematol J. 2003;4(2):151-3. doi: 10.1038/sj.thj.6200208. Hematol J. 2003. PMID: 12750735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,942 results

Search Page

Filters